Q1 EPS Estimates for CVS Health Lowered by Leerink Partnrs

CVS Health Co. (NYSE:CVS) – Research analysts at Leerink Partnrs reduced their Q1 2025 EPS estimates for CVS Health in a research note issued to investors on Saturday, October 19th. Leerink Partnrs analyst M. Cherny now expects that the pharmacy operator will post earnings of $1.49 per share for the quarter, down from their prior estimate of $1.59. The consensus estimate for CVS Health’s current full-year earnings is $6.51 per share. Leerink Partnrs also issued estimates for CVS Health’s Q2 2025 earnings at $1.82 EPS, Q3 2025 earnings at $1.86 EPS and Q4 2025 earnings at $1.80 EPS.

Several other research analysts have also issued reports on CVS. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $68.00 target price on shares of CVS Health in a research note on Wednesday, September 4th. Barclays raised shares of CVS Health from an “equal weight” rating to an “overweight” rating and raised their target price for the company from $63.00 to $82.00 in a research note on Thursday, October 10th. Truist Financial raised their target price on shares of CVS Health from $66.00 to $76.00 and gave the company a “buy” rating in a research note on Friday, October 11th. Cantor Fitzgerald reaffirmed a “neutral” rating and issued a $62.00 target price on shares of CVS Health in a research note on Tuesday, October 1st. Finally, Wells Fargo & Company increased their price target on shares of CVS Health from $60.00 to $61.00 and gave the company an “equal weight” rating in a research report on Monday, August 12th. Nine analysts have rated the stock with a hold rating and thirteen have given a buy rating to the stock. Based on data from MarketBeat.com, CVS Health has an average rating of “Moderate Buy” and a consensus price target of $75.26.

CVS Health Stock Down 2.3 %

Shares of NYSE CVS opened at $56.85 on Tuesday. The company has a market cap of $71.37 billion, a price-to-earnings ratio of 9.99, a price-to-earnings-growth ratio of 0.93 and a beta of 0.54. The company has a quick ratio of 0.66, a current ratio of 0.86 and a debt-to-equity ratio of 0.83. CVS Health has a 12-month low of $52.77 and a 12-month high of $83.25. The firm’s 50-day simple moving average is $59.87 and its 200 day simple moving average is $60.19.

CVS Health (NYSE:CVS) last announced its earnings results on Wednesday, August 7th. The pharmacy operator reported $1.83 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.73 by $0.10. CVS Health had a net margin of 1.98% and a return on equity of 12.72%. The business had revenue of $91.23 billion for the quarter, compared to analyst estimates of $91.41 billion. During the same quarter in the previous year, the firm posted $2.21 earnings per share. CVS Health’s revenue was up 2.6% compared to the same quarter last year.

CVS Health Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, November 1st. Stockholders of record on Monday, October 21st will be given a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a dividend yield of 4.68%. The ex-dividend date is Monday, October 21st. CVS Health’s dividend payout ratio is presently 46.75%.

Institutional Investors Weigh In On CVS Health

Large investors have recently made changes to their positions in the business. Wellington Management Group LLP boosted its stake in CVS Health by 33.2% in the 4th quarter. Wellington Management Group LLP now owns 219,030 shares of the pharmacy operator’s stock worth $17,295,000 after purchasing an additional 54,616 shares during the period. AdvisorNet Financial Inc raised its holdings in shares of CVS Health by 30.6% in the 1st quarter. AdvisorNet Financial Inc now owns 7,005 shares of the pharmacy operator’s stock valued at $559,000 after acquiring an additional 1,642 shares in the last quarter. Global Assets Advisory LLC purchased a new stake in shares of CVS Health in the 1st quarter valued at about $10,652,000. Annex Advisory Services LLC purchased a new stake in shares of CVS Health in the 1st quarter valued at about $300,000. Finally, Hoxton Planning & Management LLC raised its holdings in shares of CVS Health by 9.3% in the 1st quarter. Hoxton Planning & Management LLC now owns 3,991 shares of the pharmacy operator’s stock valued at $318,000 after acquiring an additional 341 shares in the last quarter. 80.66% of the stock is owned by hedge funds and other institutional investors.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.